Cite
MLA Citation
Vaishali Sanchorawala et al.. “Health‐related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study.” American journal of hematology, vol. 97, no. 6, 2022, pp. 719–730. http://access.bl.uk/ark:/81055/vdc_100155149830.0x00003b